TapImmune's New State-of-the-Art Lab Facilities and Office Space

Posted by Karen Goldfarb

January 23, 2012 at 11:19 AM

We recently received an update from TapImmune Inc. (TPIV-OTC.BB) regarding the Company's newly acquired laboratory and office space in South Lake Union (Seattle's up-and-coming biotech hub). Through a strategic sublease with the Puget Sound Blood Center Research Institute, TapImmune's scientific research team now has access to shared equipment and state-of-the-art core laboratories for DNA sequencing, Mass Spectrometry (shown below), and Fluorescent Activated Cell Sorting (FACS)—a unique opportunity for any startup company.

Read More

Topics: biotech, TapImmune, cancer vaccine, immunotherapy, Mark Reddish, Puget Sound Blood Center

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic